201 related articles for article (PubMed ID: 23700262)
1. Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients.
Krska J; Morecroft CW
Drug Saf; 2013 Aug; 36(8):673-80. PubMed ID: 23700262
[TBL] [Abstract][Full Text] [Related]
2. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand.
Patsuree A; Krska J; Jarernsiripornkul N
Expert Opin Drug Saf; 2016; 15(3):287-95. PubMed ID: 26750422
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
4. Survey of patients' experiences and their certainty of suspected adverse drug reactions.
Narumol J; Arunrot P; Krska J
Int J Clin Pharm; 2015 Feb; 37(1):168-74. PubMed ID: 25576461
[TBL] [Abstract][Full Text] [Related]
5. Utility of patient information leaflet and perceived impact of its use on medication adherence.
Al Jeraisy M; Alshammari H; Albassam M; Al Aamer K; Abolfotouh MA
BMC Public Health; 2023 Mar; 23(1):488. PubMed ID: 36918823
[TBL] [Abstract][Full Text] [Related]
6. Development and preliminary validation of an instrument to enable laypersons to assess suspected side effects from medicines.
O'Donovan B; Rodgers RM; Cox AR; Krska J
Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):1023-1031. PubMed ID: 31197912
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
Adisa R; Adeniyi OR; Fakeye TO
Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
[TBL] [Abstract][Full Text] [Related]
8. Perceived adverse drug reactions among non-institutionalized children and adolescents in Germany.
Knopf H; Du Y
Br J Clin Pharmacol; 2010 Sep; 70(3):409-17. PubMed ID: 20716242
[TBL] [Abstract][Full Text] [Related]
9. What can we learn from the public's understanding of drug information and safety? A population survey.
Salgueiro E; Gurruchaga C; Jimeno FJ; Martínez-Múgica C; Martín Arias LH; Manso G
Int J Pharm Pract; 2019 Feb; 27(1):96-104. PubMed ID: 29770980
[TBL] [Abstract][Full Text] [Related]
10. Medicine safety: experiences and perceptions of the general public in Liverpool.
Krska J; Jones L; McKinney J; Wilson C
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1098-103. PubMed ID: 21809408
[TBL] [Abstract][Full Text] [Related]
11. Use of information sources regarding medicine side effects among the general population: a cross-sectional survey.
O'Donovan B; Rodgers RM; Cox AR; Krska J
Prim Health Care Res Dev; 2019 Dec; 20():e153. PubMed ID: 31818345
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
Aagaard L; Weber CB; Hansen EH
Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
[TBL] [Abstract][Full Text] [Related]
13. Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients.
Kiguba R; Karamagi C; Bird SM
BMJ Open; 2017 Jan; 7(1):e010568. PubMed ID: 28110281
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional survey of patients' need for information and support with medicines after discharge from hospital.
Mackridge AJ; Rodgers R; Lee D; Morecroft CW; Krska J
Int J Pharm Pract; 2018 Oct; 26(5):433-441. PubMed ID: 29152842
[TBL] [Abstract][Full Text] [Related]
15. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
Hariraj V; Aziz Z
Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
[TBL] [Abstract][Full Text] [Related]
16. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
17. Herbal medicine use and linked suspected adverse drug reactions in a prospective cohort of Ugandan inpatients.
Kiguba R; Ononge S; Karamagi C; Bird SM
BMC Complement Altern Med; 2016 May; 16():145. PubMed ID: 27229463
[TBL] [Abstract][Full Text] [Related]
18. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
Jarernsiripornkul N; Patsuree A; Krska J
Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
[TBL] [Abstract][Full Text] [Related]
19. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
[TBL] [Abstract][Full Text] [Related]
20. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions.
Chaipichit N; Krska J; Pratipanawatr T; Uchaipichat V; Jarernsiripornkul N
Eur J Clin Pharmacol; 2014 May; 70(5):607-15. PubMed ID: 24531695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
